Kailera Therapeutics is trading 6.2% up today at $17.78 as the stock stages a relief rebound from a recent sector-driven slide.
- The move follows a 4.4% drop in after-hours trading on July 28, 2026, which occurred amid broader biotechnology sector weakness and risk-off sentiment.
- No new company-specific news or catalysts have been reported, suggesting the price action is driven by investors reassessing the previous day's market volatility.